Cargando…
Novel Treatment for Graft-versus-Host Disease
Allogeneic hematopoietic cell transplantation is a curative therapy for a variety of hematological diseases, but its success is hampered by acute and chronic graft-versus-host disease (GvHD). In the last five years, multiple novel therapeutic approaches for GvHD have entered the arena. The National...
Autores principales: | Inamoto, Yoshihiro, Zeiser, Robert, Chan, Godfrey Chi-Fung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847314/ https://www.ncbi.nlm.nih.gov/pubmed/36714067 http://dx.doi.org/10.31547/bct-2021-022 |
Ejemplares similares
-
Calcium Buffering in the Heart in Health and Disease
por: Smith, Godfrey L., et al.
Publicado: (2019) -
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease
por: Park, Sangwoo, et al.
Publicado: (2023) -
Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
por: Braun, Lukas M., et al.
Publicado: (2021) -
The effects of aging on host resistance and disease tolerance to SARS‐CoV‐2 infection
por: Mok, Darren Z. L., et al.
Publicado: (2020) -
Corticosteroid therapy versus physiotherapy on pain, mobility and function in shoulder impingement: A short note
por: Benjamin-Damons, Natalie, et al.
Publicado: (2022)